Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.61%113.74B | 10.82%452.92B | 17.98%104.72B | 17.73%408.69B | 20.36%114.64B | 18.20%110B | 20.46%95.29B | 11.35%88.76B | 15.76%347.13B | 16.87%95.25B |
| Cost of revenue | 10.45%82.31B | 9.01%339.77B | 15.14%74.53B | 12.55%311.7B | 19.53%95.17B | 13.38%80.86B | 12.59%70.94B | 2.75%64.73B | 9.86%276.94B | 9.70%79.63B |
| Gross profit | 4.07%31.43B | 16.65%113.15B | 25.62%30.2B | 38.18%96.99B | 24.62%19.46B | 34.00%29.14B | 51.25%24.36B | 43.72%24.04B | 46.88%70.19B | 75.28%15.62B |
| Operating expense | 10.92%14.76B | 11.00%59B | 10.29%13.3B | 9.12%53.15B | 16.53%15.12B | 9.92%13.55B | 5.02%12.42B | 4.14%12.06B | 3.54%48.71B | 5.26%12.98B |
| Operating profit | -1.32%16.67B | 23.51%54.15B | 41.07%16.89B | 104.10%43.84B | 64.37%4.34B | 65.49%15.59B | 179.05%11.94B | 132.91%11.97B | 2,802.70%21.48B | 177.24%2.64B |
| Net non-operating interest income (expenses) | -22.67%-1.1B | -19.60%-3.88B | -15.83%-900M | -11.96%-3.24B | -18.40%-875M | -6.85%-795M | -8.33%-793M | -14.43%-777M | -2.48%-2.89B | -10.63%-739M |
| Non-operating interest income | 240.00%17M | 110.53%40M | 25.00%5M | 5.56%19M | 25.00%5M | 0.00%5M | 0.00%5M | 0.00%4M | -10.00%18M | -20.00%4M |
| Non-operating interest expense | 23.87%1.12B | 20.13%3.92B | 15.88%905M | 11.92%3.26B | 18.44%880M | 6.81%800M | 8.28%798M | 14.35%781M | 2.39%2.91B | 10.40%743M |
| Net investment income | 39.45%1.07B | 17.07%1.78B | 20.00%768M | 20.40%1.52B | 19.70%237M | 21.40%607M | 10.00%33M | 20.30%640M | 1.45%1.26B | 22.98%198M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 4,723.08%627M | 13M | ||||||||
| Income from associates and other participating interests | 3.60%115M | 10.42%551M | 152.27%111M | 17.14%499M | -64.74%134M | 95.56%264M | 171.25%57M | 588.89%44M | 65.76%426M | 233.33%380M |
| Special income (charges) | -92.26%107M | 113.79%289M | 46,166.67%1.38B | -169.41%-2.1B | 114.16%333M | -223.61%-2.36B | 63.07%-65M | 98.14%-3M | -108.68%-778M | -130.93%-2.35B |
| Less:Other special charges | 92.26%-107M | -400.92%-1.31B | -46,166.67%-1.38B | 138.05%436M | -247.58%-732M | 155.58%1.1B | -63.07%65M | -98.14%3M | 89.45%-1.15B | 105.22%496M |
| Less:Write off | ---- | -38.37%1.02B | ---- | -13.72%1.66B | -78.49%399M | ---- | ---- | ---- | 1.16%1.92B | --1.86B |
| Other non-operating income (expenses) | -63.64%56M | -24.86%653M | -38.89%154M | -42.11%869M | 17.56%241M | -21.29%159M | -42.59%217M | -64.80%252M | -74.77%1.5B | -85.40%205M |
| Income before tax | -8.11%16.91B | 29.36%53.54B | 51.73%18.41B | 97.01%41.39B | 1,166.67%4.41B | 17.86%13.47B | 207.98%11.38B | 119.01%12.13B | 46.66%21.01B | -93.30%348M |
| Income tax | 28.90%4.92B | -12.23%10.56B | 15.42%3.82B | 52.73%12.04B | 895.08%485M | 79.09%5.27B | 153.28%2.98B | -13.54%3.31B | -10.64%7.88B | -102.33%-61M |
| Net income | -17.79%11.99B | 46.41%42.98B | 65.35%14.59B | 123.61%29.35B | 861.52%3.92B | -3.36%8.2B | 233.39%8.41B | 415.06%8.82B | 138.41%13.13B | -84.15%408M |
| Net income continuous operations | -17.79%11.99B | 46.41%42.98B | 65.33%14.59B | 123.59%29.35B | 859.17%3.92B | -3.36%8.2B | 233.48%8.41B | 414.82%8.82B | 138.43%13.13B | -84.11%409M |
| Noncontrolling interests | -58.54%17M | 8.26%118M | 4,200.00%41M | 738.46%109M | 147.06%42M | 537.50%51M | 1,600.00%17M | 92.31%-1M | 116.67%13M | 750.00%17M |
| Net income attributable to the company | -17.68%11.98B | 46.55%42.86B | 64.85%14.55B | 122.99%29.24B | 892.58%3.88B | -3.87%8.15B | 232.90%8.39B | 411.00%8.83B | 134.81%13.11B | -84.80%391M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -17.68%11.98B | 46.55%42.86B | 64.85%14.55B | 122.99%29.24B | 892.58%3.88B | -3.87%8.15B | 232.90%8.39B | 411.00%8.83B | 134.81%13.11B | -84.80%391M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -15.00%101.27 | 47.71%353.74 | 64.83%119.14 | 122.99%239.49 | 893.44%31.79 | -3.88%66.72 | 232.85%68.7 | 410.81%72.28 | 134.75%107.4 | -84.81%3.2 |
| Diluted earnings per share | -15.00%101.27 | 47.71%353.74 | 64.83%119.14 | 122.99%239.49 | 893.23%31.7832 | -3.88%66.72 | 232.87%68.7 | 410.81%72.28 | 134.75%107.4 | -84.81%3.2 |
| Dividend per share | 0 | 90.48%100 | 0 | 31.25%52.5 | 50.00%30 | 0 | 12.50%22.5 | 0 | 0.00%40 | 0.00%20 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |